Palvella Therapeutics (PVLA) EPS (Weighted Average and Diluted) (2020 - 2024)
Historic EPS (Weighted Average and Diluted) for Palvella Therapeutics (PVLA) over the last 5 years, with Q4 2024 value amounting to $0.12.
- Palvella Therapeutics' EPS (Weighted Average and Diluted) fell 9941.46% to $0.12 in Q4 2024 from the same period last year, while for Dec 2024 it was -$7.83, marking a year-over-year decrease of 15124.35%. This contributed to the annual value of -$7.83 for FY2024, which is 46082.95% down from last year.
- Per Palvella Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at $0.12 for Q4 2024, which was down 9941.46% from -$3.94 recorded in Q3 2024.
- In the past 5 years, Palvella Therapeutics' EPS (Weighted Average and Diluted) registered a high of $20.5 during Q4 2023, and its lowest value of -$8.7 during Q3 2023.
- For the 5-year period, Palvella Therapeutics' EPS (Weighted Average and Diluted) averaged around $0.37, with its median value being -$0.22 (2021).
- As far as peak fluctuations go, Palvella Therapeutics' EPS (Weighted Average and Diluted) plummeted by 20078.35% in 2021, and later skyrocketed by 268571.43% in 2023.
- Palvella Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.26 in 2020, then soared by 34.42% to -$0.17 in 2021, then grew by 17.89% to -$0.14 in 2022, then skyrocketed by 14742.86% to $20.5 in 2023, then tumbled by 99.41% to $0.12 in 2024.
- Its EPS (Weighted Average and Diluted) was $0.12 in Q4 2024, compared to -$3.94 in Q3 2024 and -$2.47 in Q2 2024.